Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

mRNA Sequencing Market by Sequencing Types (Product, Sequencing Platforms and Consumables, Services, Data Analysis and Management), by Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single Molecule Real Time Sequencing) and by End User (Academic and Research Institutes, Hospitals and Diagnostic Centers, Pharmaceutical Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2023-2032

A12670

Pages: NA

Charts: NA

Tables: NA

mRNA sequencing (mRNA-Seq) is the technique used for examining the transcriptomes of biological processes, disease states, and over a broad range of study designs. mRNA-Sequencing presents a comprehensive picture of the coding transcriptome. mRNA-Sequencing is an accurate & highly sensitive technique of quantifying gene expression, can identify gene fusions, novel and known transcript isoforms, and other features and allele-specific expression. In addition, mRNA-Sequencing can give strand information, which enable more accurate quantification of overlapping transcripts, increases the percentage of alignable  reads, and allows the detection of antisense expression.

COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the mRNA sequencing market.

Top Impacting Factors

  • Need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics, rise in cases of metabolic disorders, multiple sclerosis, and other diseases, growing demand for RNA Sequencing over the conventional technology, are factors that drive the growth of the mRNA sequencing market.
  • In addition, increase in healthcare expenditure; partnerships & collaborations between key players to facilitate development; rise in R&D activities are factors that boost the market growth for mRNA sequencing.
  • However, the need for skilled professionals, the huge initial capital investment on infrastructure, problems associated with the storage of sequencing data are factors that hinder the mRNA sequencing market growth.

mRNA Sequencing Market Trends

New product launches to flourish the market

Agreement & product launches are key strategies adopted by players in the RNA sequencing market.

On March 12, 2020, Thermo Fisher Scientific signed an agreement with Janssen Research & Development. The agreement aimed to develop a companion diagnostic (CDx) in the field of oncology.

On October 11, 2018, QIAGEN N.V. launched novel RNA-seq library preparation solutions for next-generation sequencing.

Key Benefits of the Report

  • This study presents the analytical depiction of the mRNA sequencing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the mRNA sequencing market share.
  • The current market is quantitatively analyzed to highlight the mRNA sequencing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the mRNA sequencing market.
  • The report provides a detailed mRNA sequencing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the mRNA sequencing Report

  • Which are the leading players active in the mRNA sequencing market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the mRNA sequencing market?
  • What future projections would help in taking further strategic steps?
  • What is "mRNA sequencing"?
  • What is "mRNA sequencing" Market prediction in the future?
  • Who are the leading global players in the "mRNA sequencing” Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "mRNA sequencing” Market report? 

 Key Market Segments

  • By Sequencing Types
    • Product
    • Sequencing Platforms and Consumables
    • Services
    • Data Analysis and Management
  • By Technology
    • Sequencing by Synthesis
    • Ion Semiconductor Sequencing
    • Nanopore Sequencing
    • Single Molecule Real Time Sequencing
  • By End User
    • Academic and Research Institutes
    • Hospitals and Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA

 
Key Market Players

  • Agilent Technologies Inc.,
  • F. Hoffmann-La Roche Ltd,
  • GE Healthcare
  • Genomatix GmbH
  • Illumina, Tecan Genomics Inc.,
  • Bio-Rad Laboratories Inc.,
  • PerkinElmer Inc.
  • Thermo Fischer Scientific
  • Beijing Genomics Institute
  • Sigma Aldrich, Eurofins Scientific

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MRNA SEQUENCING MARKET, BY SEQUENCING TYPES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Sequencing Types

    • 4.2. Product

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Sequencing Platforms And Consumables

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Services

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Data Analysis And Management

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: MRNA SEQUENCING MARKET, BY TECHNOLOGY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Technology

    • 5.2. Sequencing Synthesis

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ion Semiconductor Sequencing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Nanopore Sequencing

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Single Molecule Real Time Sequencing

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MRNA SEQUENCING MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Academic And Research Institutes

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Hospitals And Diagnostic Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Pharmaceutical And Biotechnology Companies

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: MRNA SEQUENCING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Sequencing Types

      • 7.2.3. Market Size and Forecast, By Technology

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Mrna Sequencing Market

        • 7.2.6.1. Market Size and Forecast, By Sequencing Types
        • 7.2.6.2. Market Size and Forecast, By Technology
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Mrna Sequencing Market

        • 7.2.7.1. Market Size and Forecast, By Sequencing Types
        • 7.2.7.2. Market Size and Forecast, By Technology
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Mrna Sequencing Market

        • 7.2.8.1. Market Size and Forecast, By Sequencing Types
        • 7.2.8.2. Market Size and Forecast, By Technology
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Sequencing Types

      • 7.3.3. Market Size and Forecast, By Technology

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Mrna Sequencing Market

        • 7.3.6.1. Market Size and Forecast, By Sequencing Types
        • 7.3.6.2. Market Size and Forecast, By Technology
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Mrna Sequencing Market

        • 7.3.7.1. Market Size and Forecast, By Sequencing Types
        • 7.3.7.2. Market Size and Forecast, By Technology
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Mrna Sequencing Market

        • 7.3.8.1. Market Size and Forecast, By Sequencing Types
        • 7.3.8.2. Market Size and Forecast, By Technology
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Mrna Sequencing Market

        • 7.3.9.1. Market Size and Forecast, By Sequencing Types
        • 7.3.9.2. Market Size and Forecast, By Technology
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Mrna Sequencing Market

        • 7.3.10.1. Market Size and Forecast, By Sequencing Types
        • 7.3.10.2. Market Size and Forecast, By Technology
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Mrna Sequencing Market

        • 7.3.11.1. Market Size and Forecast, By Sequencing Types
        • 7.3.11.2. Market Size and Forecast, By Technology
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Mrna Sequencing Market

        • 7.3.12.1. Market Size and Forecast, By Sequencing Types
        • 7.3.12.2. Market Size and Forecast, By Technology
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Sequencing Types

      • 7.4.3. Market Size and Forecast, By Technology

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Mrna Sequencing Market

        • 7.4.6.1. Market Size and Forecast, By Sequencing Types
        • 7.4.6.2. Market Size and Forecast, By Technology
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Mrna Sequencing Market

        • 7.4.7.1. Market Size and Forecast, By Sequencing Types
        • 7.4.7.2. Market Size and Forecast, By Technology
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Mrna Sequencing Market

        • 7.4.8.1. Market Size and Forecast, By Sequencing Types
        • 7.4.8.2. Market Size and Forecast, By Technology
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Mrna Sequencing Market

        • 7.4.9.1. Market Size and Forecast, By Sequencing Types
        • 7.4.9.2. Market Size and Forecast, By Technology
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Mrna Sequencing Market

        • 7.4.10.1. Market Size and Forecast, By Sequencing Types
        • 7.4.10.2. Market Size and Forecast, By Technology
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Mrna Sequencing Market

        • 7.4.11.1. Market Size and Forecast, By Sequencing Types
        • 7.4.11.2. Market Size and Forecast, By Technology
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Mrna Sequencing Market

        • 7.4.12.1. Market Size and Forecast, By Sequencing Types
        • 7.4.12.2. Market Size and Forecast, By Technology
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Mrna Sequencing Market

        • 7.4.13.1. Market Size and Forecast, By Sequencing Types
        • 7.4.13.2. Market Size and Forecast, By Technology
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Mrna Sequencing Market

        • 7.4.14.1. Market Size and Forecast, By Sequencing Types
        • 7.4.14.2. Market Size and Forecast, By Technology
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Sequencing Types

      • 7.5.3. Market Size and Forecast, By Technology

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Mrna Sequencing Market

        • 7.5.6.1. Market Size and Forecast, By Sequencing Types
        • 7.5.6.2. Market Size and Forecast, By Technology
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Mrna Sequencing Market

        • 7.5.7.1. Market Size and Forecast, By Sequencing Types
        • 7.5.7.2. Market Size and Forecast, By Technology
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Mrna Sequencing Market

        • 7.5.8.1. Market Size and Forecast, By Sequencing Types
        • 7.5.8.2. Market Size and Forecast, By Technology
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Mrna Sequencing Market

        • 7.5.9.1. Market Size and Forecast, By Sequencing Types
        • 7.5.9.2. Market Size and Forecast, By Technology
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Mrna Sequencing Market

        • 7.5.10.1. Market Size and Forecast, By Sequencing Types
        • 7.5.10.2. Market Size and Forecast, By Technology
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Mrna Sequencing Market

        • 7.5.11.1. Market Size and Forecast, By Sequencing Types
        • 7.5.11.2. Market Size and Forecast, By Technology
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Thermo Fischer Scientific

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Agilent Technologies Inc.,

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Illumina, Tecan Genomics Inc.,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. F. Hoffmann-La Roche Ltd,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. PerkinElmer Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. GE Healthcare

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Bio-Rad Laboratories Inc.,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Sigma Aldrich, Eurofins Scientific

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Beijing Genomics Institute

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Genomatix GmbH

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MRNA SEQUENCING MARKET, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MRNA SEQUENCING MARKET FOR PRODUCT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MRNA SEQUENCING MARKET FOR SEQUENCING PLATFORMS AND CONSUMABLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MRNA SEQUENCING MARKET FOR SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MRNA SEQUENCING MARKET FOR DATA ANALYSIS AND MANAGEMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MRNA SEQUENCING MARKET, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MRNA SEQUENCING MARKET FOR SEQUENCING SYNTHESIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MRNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MRNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MRNA SEQUENCING MARKET FOR SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MRNA SEQUENCING MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MRNA SEQUENCING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL MRNA SEQUENCING MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL MRNA SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL MRNA SEQUENCING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA MRNA SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. U.S. MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 21. U.S. MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 22. U.S. MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. CANADA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 24. CANADA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 25. CANADA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE MRNA SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. ITALY MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 40. ITALY MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 41. ITALY MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 45. UK MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 46. UK MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 47. UK MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC MRNA SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. CHINA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 59. CHINA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 60. CHINA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. INDIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 65. INDIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 66. INDIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA MRNA SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 98. UAE MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 99. UAE MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 100. UAE MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA MRNA SEQUENCING, BY SEQUENCING TYPES, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA MRNA SEQUENCING, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA MRNA SEQUENCING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 107. THERMO FISCHER SCIENTIFIC: KEY EXECUTIVES
  • TABLE 108. THERMO FISCHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 109. THERMO FISCHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 110. THERMO FISCHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 111. THERMO FISCHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. AGILENT TECHNOLOGIES INC.,: KEY EXECUTIVES
  • TABLE 113. AGILENT TECHNOLOGIES INC.,: COMPANY SNAPSHOT
  • TABLE 114. AGILENT TECHNOLOGIES INC.,: OPERATING SEGMENTS
  • TABLE 115. AGILENT TECHNOLOGIES INC.,: PRODUCT PORTFOLIO
  • TABLE 116. AGILENT TECHNOLOGIES INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ILLUMINA, TECAN GENOMICS INC.,: KEY EXECUTIVES
  • TABLE 118. ILLUMINA, TECAN GENOMICS INC.,: COMPANY SNAPSHOT
  • TABLE 119. ILLUMINA, TECAN GENOMICS INC.,: OPERATING SEGMENTS
  • TABLE 120. ILLUMINA, TECAN GENOMICS INC.,: PRODUCT PORTFOLIO
  • TABLE 121. ILLUMINA, TECAN GENOMICS INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. F. HOFFMANN-LA ROCHE LTD,: KEY EXECUTIVES
  • TABLE 123. F. HOFFMANN-LA ROCHE LTD,: COMPANY SNAPSHOT
  • TABLE 124. F. HOFFMANN-LA ROCHE LTD,: OPERATING SEGMENTS
  • TABLE 125. F. HOFFMANN-LA ROCHE LTD,: PRODUCT PORTFOLIO
  • TABLE 126. F. HOFFMANN-LA ROCHE LTD,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. PERKINELMER INC.: KEY EXECUTIVES
  • TABLE 128. PERKINELMER INC.: COMPANY SNAPSHOT
  • TABLE 129. PERKINELMER INC.: OPERATING SEGMENTS
  • TABLE 130. PERKINELMER INC.: PRODUCT PORTFOLIO
  • TABLE 131. PERKINELMER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 133. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 134. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 135. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 136. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. BIO-RAD LABORATORIES INC.,: KEY EXECUTIVES
  • TABLE 138. BIO-RAD LABORATORIES INC.,: COMPANY SNAPSHOT
  • TABLE 139. BIO-RAD LABORATORIES INC.,: OPERATING SEGMENTS
  • TABLE 140. BIO-RAD LABORATORIES INC.,: PRODUCT PORTFOLIO
  • TABLE 141. BIO-RAD LABORATORIES INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. SIGMA ALDRICH, EUROFINS SCIENTIFIC: KEY EXECUTIVES
  • TABLE 143. SIGMA ALDRICH, EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 144. SIGMA ALDRICH, EUROFINS SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 145. SIGMA ALDRICH, EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 146. SIGMA ALDRICH, EUROFINS SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. BEIJING GENOMICS INSTITUTE: KEY EXECUTIVES
  • TABLE 148. BEIJING GENOMICS INSTITUTE: COMPANY SNAPSHOT
  • TABLE 149. BEIJING GENOMICS INSTITUTE: OPERATING SEGMENTS
  • TABLE 150. BEIJING GENOMICS INSTITUTE: PRODUCT PORTFOLIO
  • TABLE 151. BEIJING GENOMICS INSTITUTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. GENOMATIX GMBH: KEY EXECUTIVES
  • TABLE 153. GENOMATIX GMBH: COMPANY SNAPSHOT
  • TABLE 154. GENOMATIX GMBH: OPERATING SEGMENTS
  • TABLE 155. GENOMATIX GMBH: PRODUCT PORTFOLIO
  • TABLE 156. GENOMATIX GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MRNA SEQUENCING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MRNA SEQUENCING MARKET
  • FIGURE 3. SEGMENTATION MRNA SEQUENCING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MRNA SEQUENCING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMRNA SEQUENCING MARKET
  • FIGURE 11. MRNA SEQUENCING MARKET SEGMENTATION, BY BY SEQUENCING TYPES
  • FIGURE 12. MRNA SEQUENCING MARKET FOR PRODUCT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MRNA SEQUENCING MARKET FOR SEQUENCING PLATFORMS AND CONSUMABLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MRNA SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MRNA SEQUENCING MARKET FOR DATA ANALYSIS AND MANAGEMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MRNA SEQUENCING MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 17. MRNA SEQUENCING MARKET FOR SEQUENCING SYNTHESIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MRNA SEQUENCING MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MRNA SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MRNA SEQUENCING MARKET FOR SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MRNA SEQUENCING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. MRNA SEQUENCING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. MRNA SEQUENCING MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. MRNA SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: MRNA SEQUENCING MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. THERMO FISCHER SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. THERMO FISCHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. THERMO FISCHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. AGILENT TECHNOLOGIES INC.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. AGILENT TECHNOLOGIES INC.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. AGILENT TECHNOLOGIES INC.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. ILLUMINA, TECAN GENOMICS INC.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. ILLUMINA, TECAN GENOMICS INC.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. ILLUMINA, TECAN GENOMICS INC.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. F. HOFFMANN-LA ROCHE LTD,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. F. HOFFMANN-LA ROCHE LTD,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. F. HOFFMANN-LA ROCHE LTD,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. PERKINELMER INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. PERKINELMER INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. PERKINELMER INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. BIO-RAD LABORATORIES INC.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. BIO-RAD LABORATORIES INC.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. BIO-RAD LABORATORIES INC.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. SIGMA ALDRICH, EUROFINS SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. SIGMA ALDRICH, EUROFINS SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. SIGMA ALDRICH, EUROFINS SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. BEIJING GENOMICS INSTITUTE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. BEIJING GENOMICS INSTITUTE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. BEIJING GENOMICS INSTITUTE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. GENOMATIX GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. GENOMATIX GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. GENOMATIX GMBH: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
mRNA Sequencing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved